7
Growth Score in past quarter
pts
Heat Score 7 in past quarter
-27 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
5090700
Acceptys is a biotechnology company focused on the development of human antibody therapies in cancer and infectious diseases.
Tony Giordano: CSOPast Role: Sulfagenix, President and CEO- Daniel Devine: CEO
About the Company
Acceptys, Inc., a biotechnology company, engages in the development of human antibody therapies in cancer and infectious diseases. It offers anti-cancer and anti-viral human antibodies for lung, pancreatic, gastric, and/or colon cancers. The company was founded in 2002 and is based in Sparta, New Jersey. As of December 3, 2008, Acceptys, Inc.
operates as a subsidiary of Patrys Limited.

